EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ultrasound-Derived Fat Fraction and Metabolic Parameters in Predicting Panvascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients: A Prospective Study

Xiangyu Qiu, Lanqing Huang, Huize Jiang, Xiahui Ren, Min Tang, Tianhui Yan, Le Xu, Chong Pei, Lei Hu

Endocrinology and Metabolism · 2026

DOI: 10.3803/enm.2025.2524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, 2026. Verfasst von Xiangyu Qiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China. Hauptthemen laut MEDLINE: Fatty Liver, Vascular Diseases, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at increased risk of panvascular disease (PD). Noninvasive markers for early risk stratification are needed. We evaluated whether ultrasound-derived fat fraction (UDFF) improves the prediction of PD occurrence in MASLD patients.

Methods

In this prospective cohort, 525 adults with MASLD were enrolled between October 2022 and December 2023 and followed for 6 months for PD occurrence. Baseline UDFF and clinical/metabolic variables were collected. Multivariable logistic regression analyses reported standardized coefficients (per-standard deviation [SD] β) and odds ratios (ORs) per 1-SD (OR). A decision tree model was constructed to explore differences across metabolic subgroups, including obesity, hypertension, diabetes, and multiple metabolic abnormalities. Discriminative performance was compared using the area under the curve (AUC; DeLong test).

Results

Body mass index (BMI), systolic blood pressure (SBP), homeostasis model assessment of insulin resistance (HOMA-IR), and UDFF were each associated with increased PD risk. In the multivariable model, the strongest standardized effects were observed for UDFF (β=3.28; OR, 2.10; 95% confidence interval [CI], 1.45 to 2.75) and BMI (β=1.87; OR, 1.68; 95% CI, 1.25 to 2.34), followed by SBP (β=1.33; OR, 1.15; 95% CI, 1.03 to 1.26). HOMA-IR (β=0.96; OR, 1.65; 95% CI, 1.30 to 2.15), age (β=0.56; OR, 1.06; 95% CI, 1.01 to 1.12), and liver stiffness measurement (β=0.14; OR, 1.03; 95% CI, 1.01 to 1.07) also showed smaller but significant associations. The decision tree model reflected similar patterns and achieved higher discrimination than logistic regression (AUC 0.85 vs. 0.80, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverVascular DiseasesMetabolic SyndromeNon-alcoholic Fatty Liver DiseaseHumansProspective StudiesFemaleMaleMiddle AgedUltrasonographyRisk FactorsInsulin ResistanceAdultRisk AssessmentBody Mass IndexPrognosis

Stichwörter der Autor:innen

Metabolic dysfunction-associated steatotic liver diseasePanvascular diseaseUltrasound-derived fat fraction

Autor:innen und Institutionen

  • Department of Ultrasound, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
  • Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
  • Graduate School, Bengbu Medical University, Bengbu, China.
  • Department of Ultrasound, People's Hospital of Changji City, Changji Hui Autonomous Prefecture, Xinjiang, China.
  • Department of Respiratory and Critical Care Medicine, The First People's Hospital of Hefei City (The Third Affiliated Hospital of Anhui Medical University), Hefei, China. pchl331@126.com.
  • Department of Ultrasound, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China. hulei@ustc.edu.cn.

Zitieren

APA

Qiu, X., Huang, L., Jiang, H., Ren, X., Tang, M., Yan, T., Xu, L., Pei, C., & Hu, L. (2026). Ultrasound-Derived Fat Fraction and Metabolic Parameters in Predicting Panvascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients: A Prospective Study. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2025.2524

Vancouver

Qiu X, Huang L, Jiang H, Ren X, Tang M, Yan T, et al. Ultrasound-Derived Fat Fraction and Metabolic Parameters in Predicting Panvascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients: A Prospective Study. Endocrinology and Metabolism. 2026. doi:10.3803/enm.2025.2524

BibTeX
@article{Qiu2026,
  author = {Qiu, Xiangyu and Huang, Lanqing and Jiang, Huize and Ren, Xiahui and Tang, Min and Yan, Tianhui and Xu, Le and Pei, Chong and Hu, Lei},
  title = {Ultrasound-Derived Fat Fraction and Metabolic Parameters in Predicting Panvascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients: A Prospective Study},
  journal = {Endocrinology and Metabolism},
  year = {2026},
  doi = {10.3803/enm.2025.2524}
}
Kostenlos starten →